Antitumor properties of (5E,7E) analogs of vitamin D3

Journal of Steroid Biochemistry and Molecular Biology

Volumn 121, Issue 1-2, 2010, Pages 399-402

  Filip, B ^a   Milczarek, M ^a   Wietrzyk, J ^a   Chodynski M ^b   Kutner, A ^b  

^a INSTITUTE OF IMMUNOLOGY AND EXPERIMENTAL THERAPY   (Poland)

^b INDUSTRIAL CHEMISTRY RESEARCH INSTITUTE   (Poland)

Author keywords

(1S,24R) 1,24 dihydroxyvitamin D3; (5E,7E) analogs antitumor activity; Calcemic effect; Calcitriol; Steroid

Indexed keywords

CALCITRIOL; CALCIUM; COLECALCIFEROL DERIVATIVE; TACALCITOL; ANTINEOPLASTIC AGENT; COLECALCIFEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CALCIUM BLOOD LEVEL; CANCER CELL CULTURE; CANCER INHIBITION; CELL PROLIFERATION; CELL STRAIN HL 60; CELL STRAIN MCF 7; CONTROLLED STUDY; DIELS ALDER REACTION; DRUG STRUCTURE; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; ISOMER; METABOLITE; MOUSE; NONHUMAN; PARENT; SYNTHESIS; TUMOR GROWTH; ANALOGS AND DERIVATIVES; ANIMAL; C57BL MOUSE; CANCER TRANSPLANTATION; CHEMISTRY; DRUG DESIGN; DRUG SCREENING; HL 60 CELL LINE; MEDICINAL CHEMISTRY; METABOLISM; PROCEDURES; STEREOISOMERISM;

ANIMALS; ANTINEOPLASTIC AGENTS; CALCIUM; CELL PROLIFERATION; CHEMISTRY, PHARMACEUTICAL; CHOLECALCIFEROL; DRUG DESIGN; DRUG SCREENING ASSAYS, ANTITUMOR; FEMALE; HL-60 CELLS; HUMANS; MICE; MICE, INBRED C57BL; NEOPLASM TRANSPLANTATION; STEREOISOMERISM;

ALNUS; MUS;

EID: 77954757655     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2010.03.017     Document Type: Article

References (16)

1. Reichel H., Koeffler H.P., Norman A.W. The role of the vitamin D endocrine system in health and disease. N. Engl. J. Med. 1989, 320(15):980-991.
2. Garland C.F., Comstock G.W., Garland F.C., Helsing K.J., Shaw E.K., Gorham E.D. Serum 25-hydroxyvitamin D and colon cancer: eight-year prospective study. Lancet 1989, 2(8673):1176-1178.
3. Newmark H.L., Lipkin M. Calcium, vitamin D, and colon cancer. Cancer Res. 1992, 52:2067s-2070s.
4. Corder E.H., Guess H.A., Hulka B.S., Friedman G.D., Sadler M., Vollmer R.T., Lobaugh B., Drezner M.K., Vogelman J.H., Orentreich N. Vitamin D and prostate cancer: a prediagnostic study with stored sera. Cancer Epidemiol. Biomarkers Prev. 1993, 2(5):467-472.
5. Cross H.S., Bareis P., Hofer H., Bischof M.G., Bajna E., Kriwanek S., Bonner E., Peterlik M. 25-Hydroxyvitamin D (3)-1alpha-hydroxylase and vitamin D receptor gene expression in human colonic mucosa is elevated during early cancerogenesis. Steroids 2001, 66(3-5):287-292.
6. Giovannucci E. The epidemiology of vitamin D and colorectal cancer: recent findings. Curr. Opin. Gastroenterol. 2006, 22(1):24-29.
7. Opolski A., Wietrzyk J., Chrobak A., Marcinkowska E., Wojdat E., Kutner A., Radzikowski C. Antiproliferative activity in vitro of side-chain analogues of calcitriol against various human normal and cancer cell lines. Anticancer Res. 1999, 19(6B):5217-5222.
8. Opolski A., Wietrzyk J., Siwinska A., Marcinkowska E., Chrobak A., Radzikowski C., Kutner A. Biological activity in vitro of side-chain modified analogues of calcitriol. Curr. Pharm. Des. 2000, 6(7):755-765.
9. 3 (PRI-2191). Steroids 2004, 69:629-635.
10. Wietrzyk J., Nevozhay D., Filip B., Milczarek M., Kutner A. The antitumor effect of lowered doses of cytostatics combined with new analogs of vitamin D in mice. Anticancer Res. 2007, 27(5A):3387-3398.
11. Wietrzyk J., Nevozhay D., Milczarek M., Filip B., Kutner A. Toxicity and antitumor activity of the vitamin D analogs PRI-1906 and PRI-1907 in combined treatment with cyclophosphamide in a mouse mammary cancer model. Cancer Chemother. Pharmacol. 2008, 62(5):787-797.
12. 3. Anticancer Drugs 2007, 18(4):447-457.
13. 3. Steroids 1980, 35(4):419-425.
14. 3: a new class of potent inhibitors of proliferation of prostate, breast, and myeloid leukemic cells. Cancer Res. 1999, 59(16):4023-4029.
15. Pols H.A., Birkenhager J.C., van J.P., Leeuwen Vitamin D analogues: from molecule to clinical application. Clin. Endocrinol. (Oxf.) 1994, 40(3):285-292.
16. 3 analog with potent ability to induce HL-60 cell differentiation without modulating calcium metabolism. Blood 1991, 78(1):75-82.